Kuwait In Vivo Cro Market Size & Outlook, 2024-2030
Kuwait in vivo cro market, 2018-2030 (US$M)
Related Markets
Kuwait in vivo cro market highlights
- The Kuwait in vivo cro market generated a revenue of USD 5.8 million in 2023 and is expected to reach USD 9.8 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 5.8 million |
| Market revenue in 2030 | USD 9.8 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.1% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 22.6 million by 2030.
Small molecule was the largest segment with a revenue share of 63.79% in 2024. Horizon Databook has segmented the Kuwait in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait's healthcare industry is experiencing significant growth, driven by increasing healthcare expenditure, growing population, and rising demand for advanced medical treatments. This growth creates opportunities for in vivo CROs to support clinical trials and drug development activities. Furthermore, the country is increasingly emphasizing research and innovation in healthcare.
The government launched initiatives to support scientific research and collaborations with academic institutions & international partners. Thus, the constant development in the R&D sector encouraged the growth of in vivo CRO services to facilitate clinical trials and advance medical knowledge.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait in vivo cro market size, by modality type, 2018-2030 (US$M)
Kuwait In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
